Passer au contenu principal

Janus kinase 3

La JAK3 gene provides instructions for making a protein that is critical for the normal development and function of the immune system. The JAK3 protein is part of a signaling pathway called the JAK/STAT pathway, which transmits chemical signals from outside the cell to the cell's nucleus. Signals relayed by the JAK3 protein regulate the growth and maturation of certain types of white blood cells (lymphocytes) called T cells and natural killer cells. In addition, JAK3 is important for the normal maturation of another type of lymphocyte called B cells. T cells, B cells, and natural killer cells attack bacteria, viruses, and fungi and help regulate the entire immune system.

Sélections vidéo pour Gènes
Bibliothèque vidéo

Normal function

La JAK3 gene provides instructions for making a protein that is critical for the normal development and function of the immune system. The JAK3 protein is part of a signaling pathway called the JAK/STAT pathway, which transmits chemical signals from outside the cell to the cell's nucleus. Signals relayed by the JAK3 protein regulate the growth and maturation of certain types of white blood cells (lymphocytes) called T cells and natural killer cells. In addition, JAK3 is important for the normal maturation of another type of lymphocyte called B cells. T cells, B cells, and natural killer cells attack bacteria, viruses, and fungi and help regulate the entire immune system.

Conditions referring to this gene or chromosome

Other names

JAK-3

JAK3_HUMAN

JAKL

Janus kinase 3 (a protein tyrosine kinase, leukocyte)

L-JAK

leukocyte Janus kinase

LJAK

tyrosine-protein kinase JAK3

Related patient information and medicines

Dyshidrose

Patient information leaflet

Dyshidrose

Its effectiveness for pompholyx is still being studied, so it is not recommended yet. Dapilumab : this medication is used for a type of eczema called atopic dermatitis. In some cases it has been shown to be helpful for the treatment of pompholyx. Janus Kinase (JAK) inhibitors : these medications, available as creams or pills, target specific.

Arthrite juvénile idiopathique

Patient information leaflet

Arthrite juvénile idiopathique

Psoriasis, eye inflammation and bowel inflammation may ... ServiceUpsellPlaceholder How is juvenile idiopathic arthritis diagnosed. The diagnosis of juvenile idiopathic arthritis (JIA) is based on the symptoms and an examination by your doctor. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is.

dystrophie musculaire

Patient information leaflet

dystrophie musculaire

Becker's muscular dystrophy (BMD) BMD is similar in many ways to DMD, but is less severe. Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to anot... MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase.

Maladies de stockage du glycogène

Patient information leaflet

Maladies de stockage du glycogène

Maladies de stockage du glycogène are a group of hérité diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Cancer primitif du foie

Patient information leaflet

Cancer primitif du foie

It is not likely to be curative for primary liver cancer but may shrink the tumour down to slow the progression of the disease. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine called a multi-targeted kinase inhibitor. It interferes with the growth of cancer cells. Research has.

Myélofibrose

Patient information leaflet

Myélofibrose

...affecting the bone marrow and its blood cell productionThe gene mutation that occurs in most people affected by myelofibrosis is a mutation in Janus Kinase 2 (JAK2). Dr Sarah Jarvis, December 2021 NICE guidance on drug treatments for myelofibrosis Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis The National.

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
  • 18 Aug 2020 | Dernière version
  • 1 août 2017 | Publié à l'origine

Participez à la conversation

Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.

Avertissement : The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Pharmacie en ligne, traitements et services de santé

Accès simple à des traitements fiables et à des services de santé en ligne.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.